NDC 0002-4182

Olumiant

Baricitinib

Olumiant is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Baricitinib.

• Product ID: 0002-4182_15ef688b-408f-4678-96b6-20068241d6db
• NDC: 0002-4182
• Product Type: Human Prescription Drug
• Proprietary Name: Olumiant
• Generic Name: Baricitinib
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2018-05-31
• Marketing Category: NDA / NDA
• Application Number: NDA207924
• Labeler Name: Eli Lilly and Company
• Substance Name: BARICITINIB
• Active Ingredient Strength: 2 mg/1
• Pharm Classes: Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0002-4182-30

30 TABLET, FILM COATED in 1 BOTTLE (0002-4182-30)

• Marketing Start Date: 2018-05-31
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0002-4182-61 [00002418261]

Olumiant TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA207924
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2018-05-31

NDC 0002-4182-30 [00002418230]

Olumiant TABLET, FILM COATED

• Marketing Category: NDA
• Application Number: NDA207924
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2018-05-31

Drug Details

Active Ingredients

Ingredient	Strength
BARICITINIB	2 mg/1

OpenFDA Data

• SPL SET ID: 866e9f35-9035-4581-a4b1-75a621ab55cf
• Manufacturer:
  • Eli Lilly and Company
• UNII:
  • ISP4442I3Y
• RxNorm Concept Unique ID - RxCUI:
  • 2047247
  • 2047241

Pharmacological Class

• Janus Kinase Inhibitor [EPC]
• Janus Kinase Inhibitors [MoA]

NDC Crossover Matching brand name "Olumiant" or generic name "Baricitinib"

NDC	Brand Name	Generic Name
0002-4182	Olumiant	baricitinib
0002-4479	Olumiant	baricitinib
0002-4732	Olumiant	baricitinib
0002-6885	Baricitinib	baricitinib